Institutional Ownership
Galmed Pharmaceuticals Ltd
CUSIP M47238148SHSGLMDQ1 2026
Institutional Holders
16
13F filers
Shares Held
145.8K
Aggregate institutional
Institutional Value
$71.2K
Q1 2026
Net New Holders
+0
0 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions0
Increased4
Decreased5
Sold out0
Institutional Holders
16 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Two Sigma Investments, LP | 80.2K | $39.3K | −32.0K | Reduced |
| 2 | Xtx Topco Ltd | 22.4K | $10.8K | +11.3K | Added |
| 3 | Jane Street Group, LLC | 16.4K | $8.1K | +4.3K | Added |
| 4 | Two Sigma Securities, LLC | 12.0K | $5.9K | −1.6K | Reduced |
| 5 | Citadel Advisors LLC | 11.4K | $5.5K | −26.8K | Reduced |
| 6 | Ubs Group AG | 2.5K | $1.2K | +732 | Added |
| 7 | Bnp Paribas Financial Markets | 600 | $294 | −300 | Reduced |
| 8 | Morgan Stanley | 157 | $77 | −141 | Reduced |
| 9 | Wells Fargo & Company/Mn | 43 | $21 | +34 | Added |
| 10 | Sbi Securities Co., Ltd. | 16 | $8 | 0 | Held |
6 more institutional holders on Premium
See every fund holding Galmed Pharmaceuticals Ltd, with full quarter-over-quarter share changes.
Unlock all holders